Johannes Nippgen, MD, PhD, is Chief Medical Officer for Alphamab Oncology. He passionately aspires to innovation and improvement and strives towards bringing healthcare R&D in China to global leadership.After graduating in Medicine in Mainz, Germany, and earning his doctorate in Wurzburg, Germany, Johannes started his professional career as surgical oncologist. He holds German and European board certifications in Urology/ GU-oncology and published in various regional and international journals including the New England Journal of Medicine. Before joined Alphamab Oncology, he was the Head of R&D for Merck China.